Last reviewed · How we verify
NCT02430233
Vaginal Progesterone for the Prolongation of Pregnancy After Arrested Pre-term Labor
Phase 4 trial testing micronized progesterone 400 mg (Utrogestan) in Preterm Labor in 129 participants. Completed in 27 February 2023.
27 February 2023
Quick facts
| Lead sponsor | HaEmek Medical Center, Israel |
|---|---|
| Phase | Phase 4 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 129 |
| Start date | 19 December 2018 |
| Primary completion | 27 February 2023 |
| Estimated completion | 27 February 2023 |
| Sites | 3 locations across Israel |
Drugs / interventions tested
- micronized progesterone 400 mg (Utrogestan) — full drug profile →
Conditions studied
- Preterm Labor — all drugs for Preterm Labor →
Sponsor
HaEmek Medical Center, Israel
Who can join
18 and older, female only, with Preterm Labor. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patients diagnosed with arrested pre-term labor following tocolytics at 24-34 gestational weeks will be randomly allocated to receive either vaginal micronized progesterone 400 mg/day or no treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Vaginal Progesterone for Pregnancy Prolongation After Arrested Preterm Labor: A Randomized Clinical Trial.
Nachum Z, Ganor Paz Y, Massalha M, Wated M, et al · · 2024 · cited 4× · PMID 38976270 · DOI 10.1001/jamanetworkopen.2024.19894
Verify or expand the search:
- PubMed search for NCT02430233
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Preterm Labor
Currently open trials in the same condition.
- NCT07015203 — The Combined First Trimester Screening · recruiting
- NCT07263490 — PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients) · recruiting
- NCT06053697 — Is the Vaginal Microbiome and Metabolome Associated With Spontaneous Preterm Birth (sPTB) in Multiple Pregnancies? · active not recruiting
- NCT05698966 — Low Dose Antenatal Corticosteroids for Late Preterm Delivery · NA · recruiting
- NCT06074601 — MIRACLE of LIFE Study · active not recruiting
Other HaEmek Medical Center, Israel trials
Trials by the same sponsor.
- NCT06656286 — Hysteroscopic Intrauterine Suturing · NA · not yet recruiting
- NCT06803992 — Induction of Labor - Comparison Propess With Prostaglandin E2 Vaginal Gel and Balloon Catheter · Phase 4 · recruiting
- NCT06542367 — Trans Canal Tympanoplasty With Local Anesthesia Using Fat Graft and "TachoSil" · NA · not yet recruiting
- NCT05732155 — Preliminary Effectiveness of Individual and Group MDMA-assisted Therapy for Israeli Veterans With PTSD and Moral Injury. · Phase 2 · unknown
- NCT05933018 — Night Hyperglycemia and Fatty Liver in Type 1 Diabetes · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02430233 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by HaEmek Medical Center, Israel
- Last refreshed: 28 February 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02430233.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing